Sanofi All In on Digital Drugmaking. Digitization has allowed Sanofi to optimize manufacturing and automate document preparation.@sanofi.#AI #automation #biomanufacturing.

Wacker and Gearbox Biosciences Join Forces on Plasmid DNA Manufacturing. Work on the collaboration will be carried out at the recently opened Wacker Biotechnology Center at the company’s central R&D site in Munich.@wackerchemie.#biomanufacturing #plasmids.

Computational Models Forecast C. diff Infections Before They Develop. With further development, the models could someday help select tailored probiotics for C. diff infections based on patients' #gut ecosystems.@isbsci.#bacteria #computationalbiology.

Alzheimer’s Therapy Delivery Boosted with Engineered Antibody. The newly designed antibody transport vesicle holds promise as a potential solution to the challenges of current AD therapies.@biogen.#DenaliTherapeutics #Azheimersdisease #antibodies.

Asthma Drug Prevents Food-Related Anaphylaxis in Allergic Mice. Data from two studies reveal a critical role of leukotrienes in anaphylactic reaction to ingested allergens.@YaleMed @NUFeinbergMed.#anaphylaxis #allergens #asthmadrug.

10x Genomics Scales Up, Agrees to Acquire Scale Biosciences. An exclusive interview with Serge Saxonov, PhD, of @10xGenomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.@scalebio.#industrynews #genomics.

NEW WEBINAR! On 8/21, David Ezra Gordon, PhD, will describe a proteomics-driven approach for studying T-cell exhaustion to identify potential immunotherapy targets. Register now to join us for this free webinar sponsored by @bruker: #immunotherapy

Cheaper Sequencing Means More Single Cells. Ultima Genomics, Gilad Almogy, PhD, discusses the momentum surrounding single-cell genomics and his excitement about being a part of it.@UltimaGenomics.#singlecellgenomics #AI #ChatGPT.

Cytiva Expands Collaboration with Culture Biosciences. Cytiva will serve as the exclusive global distributor of Culture’s Stratyx 250 bioreactor platform and associated consumables.@Cytiva @culturebiosci.#bioreactors #bioprocessing.

Novel Non-Opioid Analgesic May Offer Hope Amid U.S. Opioid Crisis. A non-opioid analgesic, called ADRIANA, targets α2B-adrenoceptors with promising Phase II results in Japan.@KyotoU_News.#painmanagement #opioiduse #chronicpain.

Microglia Replacement Strategy Mitigates Rare Neurodegenerative Disease in Mice. Mice that underwent brain-specific #microglia transplantation retained most of their injected cells and lived longer than the control group.@WernigLab.#neurodegeneration.

Out of Thin Air: Hypoxia Reverses Parkinson’s Symptoms in Mice. Hypoxia may be a promising therapy path to address Parkinson's neurodegeneration caused by excessive oxygen levels in the brain.@VamsiMootha @broadinstitute.#Parkinsons #hypoxia #neurons.

Alzheimer’s Pathology Reversed, Memory Restored with Lithium Compound in Mice. The new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different therapeutic approach.@harvardmed.#Azheimers #lithium #brain.

Expanding Global Access to Precision Medicine. Investing in sponsored testing approaches is critical for translating scientific innovation into equitable clinical access. Sponsored by @SOPHiAGENETICS.#PrecisionMedicine #genetics #biopharma.

CHO Plus Signs Two mAb Production Deals, Joins 2025 BioTools Accelerator. In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements. #biomanufacturing #mAb #CHOPlus.

Nanoparticles Slow Disease Progression and Reduce Flare Severity in RA Mouse Model. Agg-CLNP synergized with abatacept to delay RA-related #inflammation and with dexamethasone to prevent flare-ups following steroid withdrawal.@CNE_Nano.#RA #nanoparticles.

3 BLAs in 3 Years: Ocugen Sees Potential in Eye Disease Gene Therapies. Ocugen says it is on track to reshape the market for gene therapies against #eyedisorders over the next three years, including blindness-related diseases.@Ocugen.#genetherapy #AAV.

RNA Splicing Mechanism Opens Path to Treat Diabetes. HNF1A mutations are found to dysregulate RNA #splicing in pancreatic cells, thereby contributing to the onset of diabetes.@1jorgeferrer @CRGenomica.#diabetes #RNA.

Immune-Independent Bacterial Therapy Destroys Tumors in Mice. A bacteria-based cancer therapy has been engineered that eradicates tumors in #immunocompromised mice—no immune cells required.@JaistMs @DaiichiSankyo @UofTsukuba.#bacteria #cancertherapy.

Repligen Partners with Novasign to Further Advance Bioprocessing Digitalization. The fusion of intelligent modeling workflows, PAT, and smart devices will allow #biomanufacturers to drastically reduce #development costs.@Repligen @Novasign_GmbH.#AI.